XRTX XORTX Therapeutics Inc.


$ 0.63 $ 0.00 (0 %)    

Tuesday, 04-Nov-2025 09:32:49 EST
QQQ $ 621.97 $ -1.31 (-0.21 %)
DIA $ 469.46 $ -0.96 (-0.2 %)
SPY $ 675.27 $ -0.91 (-0.13 %)
TLT $ 89.82 $ 0.04 (0.04 %)
GLD $ 362.20 $ -1.45 (-0.4 %)
$ na
$ 0.63
$ 0.62 x 100
$ 0.64 x 1,667
$ 0.63 - $ 0.63
$ 0.57 - $ 1.79
779,731
na
2.42M
$ 4.07
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU))), a late stage cli...

Core News & Articles

Gainers Galecto (NASDAQ: GLTO) stock rose 21.6% to $5.41 during Thursday's after-market session. The market value of their...

 xortx-therapeutics-issues-73871-shares-at-154-in-q1-2025-raising-net-proceeds-of-1097k-under-atm-program

Issuance of Shares under ATM OfferingIn other news, the Company confirms the issuance of 73,871 common shares at US$1.54 (CAD $...

Core News & Articles

XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU))), a late stage cli...

Core News & Articles

XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU))), a late stage cli...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION